cefoxitin Search Results


90
Gold Biotechnology Inc cefoxitin
Cefoxitin, supplied by Gold Biotechnology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cefoxitin/Cefoxitin/pm29274964-92-56-57
Average 90 stars, based on 1 article reviews
cefoxitin - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

93
Thermo Fisher cefoxitin sodium salt
Impact of different β-lactam antibiotics on the PG structure of vegetative cells of C. difficile wild type and ΔΔΔ ldt (A) LC-MS chromatogram of muropeptides from vegetative cells of C. difficile wild-type (WT) strain grown in the presence of subinhibitory concentrations of <t>cefoxitin.</t> Peak labels refer to <xref ref-type=Table S1 . New major peaks observed in the presence of the antibiotics are labeled with letters. See also Table S1 for the structure of all identified muropeptides. Data are representative of three independent experiments. (B) Abundance of muropeptides with a tetrapeptide or a pentapeptide stem (free side or acceptor chain in multimers) in the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (C) Abundance of muropeptide dimers with a 4→3 and a 3→3 cross-link relative to total muropeptides in the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (D) Cross-linking index of the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (E) Abundance of muropeptide dimers with a 3→3 cross-link relative to the total cross-links in dimers in the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (F) Abundance of muropeptides with a pentapeptide stem ending with a non-canonical d -amino-acid (NCDAA: Gly, Phe, Leu, or Val) (Penta-NCDAA ) relative to the total pentapeptide muropeptides in the C. difficile wild-type and ΔΔΔ ldt strains grown in the presence of cefoxitin or meropenem. All graphs represent mean ± SEM and include individual data points; n = 3 independent experiments. ∗∗∗ p ≤ 0.01 and ∗∗∗∗ p ≤ 0.001 by a two-way ANOVA followed by a Dunnett’s multiple comparisons test. " width="250" height="auto" />
Cefoxitin Sodium Salt, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cefoxitin/Cefoxitin+sodium+salt%2C+94%25/pmc11986978-29-0-4
Average 93 stars, based on 1 article reviews
cefoxitin sodium salt - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

92
Santa Cruz Biotechnology cefoxitin
Impact of different β-lactam antibiotics on the PG structure of vegetative cells of C. difficile wild type and ΔΔΔ ldt (A) LC-MS chromatogram of muropeptides from vegetative cells of C. difficile wild-type (WT) strain grown in the presence of subinhibitory concentrations of <t>cefoxitin.</t> Peak labels refer to <xref ref-type=Table S1 . New major peaks observed in the presence of the antibiotics are labeled with letters. See also Table S1 for the structure of all identified muropeptides. Data are representative of three independent experiments. (B) Abundance of muropeptides with a tetrapeptide or a pentapeptide stem (free side or acceptor chain in multimers) in the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (C) Abundance of muropeptide dimers with a 4→3 and a 3→3 cross-link relative to total muropeptides in the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (D) Cross-linking index of the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (E) Abundance of muropeptide dimers with a 3→3 cross-link relative to the total cross-links in dimers in the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (F) Abundance of muropeptides with a pentapeptide stem ending with a non-canonical d -amino-acid (NCDAA: Gly, Phe, Leu, or Val) (Penta-NCDAA ) relative to the total pentapeptide muropeptides in the C. difficile wild-type and ΔΔΔ ldt strains grown in the presence of cefoxitin or meropenem. All graphs represent mean ± SEM and include individual data points; n = 3 independent experiments. ∗∗∗ p ≤ 0.01 and ∗∗∗∗ p ≤ 0.001 by a two-way ANOVA followed by a Dunnett’s multiple comparisons test. " width="250" height="auto" />
Cefoxitin, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cefoxitin/Cefoxitin/pm32380006-393-28-29
Average 92 stars, based on 1 article reviews
cefoxitin - by Bioz Stars, 2026-09
92/100 stars
  Buy from Supplier

90
Biosynth Carbosynth cefoxitin
Impact of different β-lactam antibiotics on the PG structure of vegetative cells of C. difficile wild type and ΔΔΔ ldt (A) LC-MS chromatogram of muropeptides from vegetative cells of C. difficile wild-type (WT) strain grown in the presence of subinhibitory concentrations of <t>cefoxitin.</t> Peak labels refer to <xref ref-type=Table S1 . New major peaks observed in the presence of the antibiotics are labeled with letters. See also Table S1 for the structure of all identified muropeptides. Data are representative of three independent experiments. (B) Abundance of muropeptides with a tetrapeptide or a pentapeptide stem (free side or acceptor chain in multimers) in the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (C) Abundance of muropeptide dimers with a 4→3 and a 3→3 cross-link relative to total muropeptides in the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (D) Cross-linking index of the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (E) Abundance of muropeptide dimers with a 3→3 cross-link relative to the total cross-links in dimers in the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (F) Abundance of muropeptides with a pentapeptide stem ending with a non-canonical d -amino-acid (NCDAA: Gly, Phe, Leu, or Val) (Penta-NCDAA ) relative to the total pentapeptide muropeptides in the C. difficile wild-type and ΔΔΔ ldt strains grown in the presence of cefoxitin or meropenem. All graphs represent mean ± SEM and include individual data points; n = 3 independent experiments. ∗∗∗ p ≤ 0.01 and ∗∗∗∗ p ≤ 0.001 by a two-way ANOVA followed by a Dunnett’s multiple comparisons test. " width="250" height="auto" />
Cefoxitin, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cefoxitin/Cefoxitin/pmc04649200-122-11-13
Average 90 stars, based on 1 article reviews
cefoxitin - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

88
Selleck Chemicals cefoxitin cfx
Impact of different β-lactam antibiotics on the PG structure of vegetative cells of C. difficile wild type and ΔΔΔ ldt (A) LC-MS chromatogram of muropeptides from vegetative cells of C. difficile wild-type (WT) strain grown in the presence of subinhibitory concentrations of <t>cefoxitin.</t> Peak labels refer to <xref ref-type=Table S1 . New major peaks observed in the presence of the antibiotics are labeled with letters. See also Table S1 for the structure of all identified muropeptides. Data are representative of three independent experiments. (B) Abundance of muropeptides with a tetrapeptide or a pentapeptide stem (free side or acceptor chain in multimers) in the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (C) Abundance of muropeptide dimers with a 4→3 and a 3→3 cross-link relative to total muropeptides in the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (D) Cross-linking index of the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (E) Abundance of muropeptide dimers with a 3→3 cross-link relative to the total cross-links in dimers in the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (F) Abundance of muropeptides with a pentapeptide stem ending with a non-canonical d -amino-acid (NCDAA: Gly, Phe, Leu, or Val) (Penta-NCDAA ) relative to the total pentapeptide muropeptides in the C. difficile wild-type and ΔΔΔ ldt strains grown in the presence of cefoxitin or meropenem. All graphs represent mean ± SEM and include individual data points; n = 3 independent experiments. ∗∗∗ p ≤ 0.01 and ∗∗∗∗ p ≤ 0.001 by a two-way ANOVA followed by a Dunnett’s multiple comparisons test. " width="250" height="auto" />
Cefoxitin Cfx, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cefoxitin/Cefoxitin/pm40930792-29-27-42
Average 88 stars, based on 1 article reviews
cefoxitin cfx - by Bioz Stars, 2026-09
88/100 stars
  Buy from Supplier

96
Chem Impex International cefoxitin
Impact of different β-lactam antibiotics on the PG structure of vegetative cells of C. difficile wild type and ΔΔΔ ldt (A) LC-MS chromatogram of muropeptides from vegetative cells of C. difficile wild-type (WT) strain grown in the presence of subinhibitory concentrations of <t>cefoxitin.</t> Peak labels refer to <xref ref-type=Table S1 . New major peaks observed in the presence of the antibiotics are labeled with letters. See also Table S1 for the structure of all identified muropeptides. Data are representative of three independent experiments. (B) Abundance of muropeptides with a tetrapeptide or a pentapeptide stem (free side or acceptor chain in multimers) in the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (C) Abundance of muropeptide dimers with a 4→3 and a 3→3 cross-link relative to total muropeptides in the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (D) Cross-linking index of the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (E) Abundance of muropeptide dimers with a 3→3 cross-link relative to the total cross-links in dimers in the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (F) Abundance of muropeptides with a pentapeptide stem ending with a non-canonical d -amino-acid (NCDAA: Gly, Phe, Leu, or Val) (Penta-NCDAA ) relative to the total pentapeptide muropeptides in the C. difficile wild-type and ΔΔΔ ldt strains grown in the presence of cefoxitin or meropenem. All graphs represent mean ± SEM and include individual data points; n = 3 independent experiments. ∗∗∗ p ≤ 0.01 and ∗∗∗∗ p ≤ 0.001 by a two-way ANOVA followed by a Dunnett’s multiple comparisons test. " width="250" height="auto" />
Cefoxitin, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cefoxitin/Cefoxitin+sodium+salt/pm37438331-294-43-44
Average 96 stars, based on 1 article reviews
cefoxitin - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

94
Selleck Chemicals cefoxitin sodium
Impact of different β-lactam antibiotics on the PG structure of vegetative cells of C. difficile wild type and ΔΔΔ ldt (A) LC-MS chromatogram of muropeptides from vegetative cells of C. difficile wild-type (WT) strain grown in the presence of subinhibitory concentrations of <t>cefoxitin.</t> Peak labels refer to <xref ref-type=Table S1 . New major peaks observed in the presence of the antibiotics are labeled with letters. See also Table S1 for the structure of all identified muropeptides. Data are representative of three independent experiments. (B) Abundance of muropeptides with a tetrapeptide or a pentapeptide stem (free side or acceptor chain in multimers) in the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (C) Abundance of muropeptide dimers with a 4→3 and a 3→3 cross-link relative to total muropeptides in the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (D) Cross-linking index of the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (E) Abundance of muropeptide dimers with a 3→3 cross-link relative to the total cross-links in dimers in the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (F) Abundance of muropeptides with a pentapeptide stem ending with a non-canonical d -amino-acid (NCDAA: Gly, Phe, Leu, or Val) (Penta-NCDAA ) relative to the total pentapeptide muropeptides in the C. difficile wild-type and ΔΔΔ ldt strains grown in the presence of cefoxitin or meropenem. All graphs represent mean ± SEM and include individual data points; n = 3 independent experiments. ∗∗∗ p ≤ 0.01 and ∗∗∗∗ p ≤ 0.001 by a two-way ANOVA followed by a Dunnett’s multiple comparisons test. " width="250" height="auto" />
Cefoxitin Sodium, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cefoxitin/Cefoxitin+sodium/pmc12134865-62-6-31
Average 94 stars, based on 1 article reviews
cefoxitin sodium - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

94
Thermo Fisher cefoxitin
Impact of different β-lactam antibiotics on the PG structure of vegetative cells of C. difficile wild type and ΔΔΔ ldt (A) LC-MS chromatogram of muropeptides from vegetative cells of C. difficile wild-type (WT) strain grown in the presence of subinhibitory concentrations of <t>cefoxitin.</t> Peak labels refer to <xref ref-type=Table S1 . New major peaks observed in the presence of the antibiotics are labeled with letters. See also Table S1 for the structure of all identified muropeptides. Data are representative of three independent experiments. (B) Abundance of muropeptides with a tetrapeptide or a pentapeptide stem (free side or acceptor chain in multimers) in the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (C) Abundance of muropeptide dimers with a 4→3 and a 3→3 cross-link relative to total muropeptides in the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (D) Cross-linking index of the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (E) Abundance of muropeptide dimers with a 3→3 cross-link relative to the total cross-links in dimers in the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (F) Abundance of muropeptides with a pentapeptide stem ending with a non-canonical d -amino-acid (NCDAA: Gly, Phe, Leu, or Val) (Penta-NCDAA ) relative to the total pentapeptide muropeptides in the C. difficile wild-type and ΔΔΔ ldt strains grown in the presence of cefoxitin or meropenem. All graphs represent mean ± SEM and include individual data points; n = 3 independent experiments. ∗∗∗ p ≤ 0.01 and ∗∗∗∗ p ≤ 0.001 by a two-way ANOVA followed by a Dunnett’s multiple comparisons test. " width="250" height="auto" />
Cefoxitin, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cefoxitin/CEFOXITIN+98/pm19429748-43-19-20
Average 94 stars, based on 1 article reviews
cefoxitin - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

90
AB Biodisk North American Inc cefoxitin disc-diffusion method
Impact of different β-lactam antibiotics on the PG structure of vegetative cells of C. difficile wild type and ΔΔΔ ldt (A) LC-MS chromatogram of muropeptides from vegetative cells of C. difficile wild-type (WT) strain grown in the presence of subinhibitory concentrations of <t>cefoxitin.</t> Peak labels refer to <xref ref-type=Table S1 . New major peaks observed in the presence of the antibiotics are labeled with letters. See also Table S1 for the structure of all identified muropeptides. Data are representative of three independent experiments. (B) Abundance of muropeptides with a tetrapeptide or a pentapeptide stem (free side or acceptor chain in multimers) in the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (C) Abundance of muropeptide dimers with a 4→3 and a 3→3 cross-link relative to total muropeptides in the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (D) Cross-linking index of the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (E) Abundance of muropeptide dimers with a 3→3 cross-link relative to the total cross-links in dimers in the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (F) Abundance of muropeptides with a pentapeptide stem ending with a non-canonical d -amino-acid (NCDAA: Gly, Phe, Leu, or Val) (Penta-NCDAA ) relative to the total pentapeptide muropeptides in the C. difficile wild-type and ΔΔΔ ldt strains grown in the presence of cefoxitin or meropenem. All graphs represent mean ± SEM and include individual data points; n = 3 independent experiments. ∗∗∗ p ≤ 0.01 and ∗∗∗∗ p ≤ 0.001 by a two-way ANOVA followed by a Dunnett’s multiple comparisons test. " width="250" height="auto" />
Cefoxitin Disc Diffusion Method, supplied by AB Biodisk North American Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cefoxitin/cefoxitin+disc+diffusion+method/pmc03071171-52-11-18
Average 90 stars, based on 1 article reviews
cefoxitin disc-diffusion method - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Lab M Ltd brazier’s cefoxitin-cycloserine egg yolk agar (ccey
Impact of different β-lactam antibiotics on the PG structure of vegetative cells of C. difficile wild type and ΔΔΔ ldt (A) LC-MS chromatogram of muropeptides from vegetative cells of C. difficile wild-type (WT) strain grown in the presence of subinhibitory concentrations of <t>cefoxitin.</t> Peak labels refer to <xref ref-type=Table S1 . New major peaks observed in the presence of the antibiotics are labeled with letters. See also Table S1 for the structure of all identified muropeptides. Data are representative of three independent experiments. (B) Abundance of muropeptides with a tetrapeptide or a pentapeptide stem (free side or acceptor chain in multimers) in the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (C) Abundance of muropeptide dimers with a 4→3 and a 3→3 cross-link relative to total muropeptides in the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (D) Cross-linking index of the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (E) Abundance of muropeptide dimers with a 3→3 cross-link relative to the total cross-links in dimers in the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (F) Abundance of muropeptides with a pentapeptide stem ending with a non-canonical d -amino-acid (NCDAA: Gly, Phe, Leu, or Val) (Penta-NCDAA ) relative to the total pentapeptide muropeptides in the C. difficile wild-type and ΔΔΔ ldt strains grown in the presence of cefoxitin or meropenem. All graphs represent mean ± SEM and include individual data points; n = 3 independent experiments. ∗∗∗ p ≤ 0.01 and ∗∗∗∗ p ≤ 0.001 by a two-way ANOVA followed by a Dunnett’s multiple comparisons test. " width="250" height="auto" />
Brazier’s Cefoxitin Cycloserine Egg Yolk Agar (Ccey, supplied by Lab M Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cefoxitin/brazier%E2%80%99s+cefoxitin+cycloserine+egg+yolk+agar++ccey/pmc04149523-91-30-35
Average 90 stars, based on 1 article reviews
brazier’s cefoxitin-cycloserine egg yolk agar (ccey - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Banyu Pharmaceutical cefoxitin
Susceptibilities of E. cloacae 8009 and various transformants to β-lactams
Cefoxitin, supplied by Banyu Pharmaceutical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cefoxitin/cefoxitin/pmc00089069-130-45-46
Average 90 stars, based on 1 article reviews
cefoxitin - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Merck KGaA cefoxitin (30 discs)
Susceptibilities of E. cloacae 8009 and various transformants to β-lactams
Cefoxitin (30 Discs), supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cefoxitin/cefoxitin++30+discs+/pmc07777544-44-10-17
Average 90 stars, based on 1 article reviews
cefoxitin (30 discs) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Impact of different β-lactam antibiotics on the PG structure of vegetative cells of C. difficile wild type and ΔΔΔ ldt (A) LC-MS chromatogram of muropeptides from vegetative cells of C. difficile wild-type (WT) strain grown in the presence of subinhibitory concentrations of cefoxitin. Peak labels refer to <xref ref-type=Table S1 . New major peaks observed in the presence of the antibiotics are labeled with letters. See also Table S1 for the structure of all identified muropeptides. Data are representative of three independent experiments. (B) Abundance of muropeptides with a tetrapeptide or a pentapeptide stem (free side or acceptor chain in multimers) in the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (C) Abundance of muropeptide dimers with a 4→3 and a 3→3 cross-link relative to total muropeptides in the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (D) Cross-linking index of the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (E) Abundance of muropeptide dimers with a 3→3 cross-link relative to the total cross-links in dimers in the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (F) Abundance of muropeptides with a pentapeptide stem ending with a non-canonical d -amino-acid (NCDAA: Gly, Phe, Leu, or Val) (Penta-NCDAA ) relative to the total pentapeptide muropeptides in the C. difficile wild-type and ΔΔΔ ldt strains grown in the presence of cefoxitin or meropenem. All graphs represent mean ± SEM and include individual data points; n = 3 independent experiments. ∗∗∗ p ≤ 0.01 and ∗∗∗∗ p ≤ 0.001 by a two-way ANOVA followed by a Dunnett’s multiple comparisons test. " width="100%" height="100%">

Journal: iScience

Article Title: The l,d -transpeptidation pathway is inhibited by antibiotics of the β-lactam class in Clostridioides difficile

doi: 10.1016/j.isci.2025.112227

Figure Lengend Snippet: Impact of different β-lactam antibiotics on the PG structure of vegetative cells of C. difficile wild type and ΔΔΔ ldt (A) LC-MS chromatogram of muropeptides from vegetative cells of C. difficile wild-type (WT) strain grown in the presence of subinhibitory concentrations of cefoxitin. Peak labels refer to Table S1 . New major peaks observed in the presence of the antibiotics are labeled with letters. See also Table S1 for the structure of all identified muropeptides. Data are representative of three independent experiments. (B) Abundance of muropeptides with a tetrapeptide or a pentapeptide stem (free side or acceptor chain in multimers) in the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (C) Abundance of muropeptide dimers with a 4→3 and a 3→3 cross-link relative to total muropeptides in the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (D) Cross-linking index of the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (E) Abundance of muropeptide dimers with a 3→3 cross-link relative to the total cross-links in dimers in the PG of C. difficile wild-type and ΔΔΔ ldt strains grown in the absence of antibiotics (no ATB) or in the presence of cefoxitin or meropenem. (F) Abundance of muropeptides with a pentapeptide stem ending with a non-canonical d -amino-acid (NCDAA: Gly, Phe, Leu, or Val) (Penta-NCDAA ) relative to the total pentapeptide muropeptides in the C. difficile wild-type and ΔΔΔ ldt strains grown in the presence of cefoxitin or meropenem. All graphs represent mean ± SEM and include individual data points; n = 3 independent experiments. ∗∗∗ p ≤ 0.01 and ∗∗∗∗ p ≤ 0.001 by a two-way ANOVA followed by a Dunnett’s multiple comparisons test.

Article Snippet: Cefoxitin sodium salt , Thermo Scientific , 455280050.

Techniques: Liquid Chromatography with Mass Spectroscopy, Labeling

Journal: iScience

Article Title: The l,d -transpeptidation pathway is inhibited by antibiotics of the β-lactam class in Clostridioides difficile

doi: 10.1016/j.isci.2025.112227

Figure Lengend Snippet:

Article Snippet: Cefoxitin sodium salt , Thermo Scientific , 455280050.

Techniques: Recombinant, Sequencing, Software, Targeted Proteomics

Susceptibilities of E. cloacae 8009 and various transformants to β-lactams

Journal:

Article Title: Characterization of SFO-1, a Plasmid-Mediated Inducible Class A ?-Lactamase from Enterobacter cloacae

doi:

Figure Lengend Snippet: Susceptibilities of E. cloacae 8009 and various transformants to β-lactams

Article Snippet: Imipenem-cilastatin (Banyu, Tokyo, Japan), ceftazidime (Glaxo Japan, Tokyo, Japan), cefoperazone (Toyama, Tokyo, Japan), moxalactam (Shionogi, Osaka, Japan), aztreonam (Eisai, Tokyo, Japan), cefpiramide (Sumitomo, Osaka, Japan), ceftizoxime (Fujisawa, Osaka, Japan), cefotaxime (Chugai, Tokyo, Japan), cefmenoxime (Takeda, Osaka, Japan), ceftriaxone (Roche, Tokyo, Japan), cefuroxime (Glaxo), cefotiam (Takeda), cefoxitin (Banyu), cefamandole (Shionogi), cefazolin (Fujisawa), cephalothin (Shionogi), cephaloridine (Shionogi), and ampicillin (Fujisawa) were used.

Techniques: